Search

Your search keyword '"Huang, Jennifer"' showing total 1,332 results

Search Constraints

Start Over You searched for: Author "Huang, Jennifer" Remove constraint Author: "Huang, Jennifer"
1,332 results on '"Huang, Jennifer"'

Search Results

2. Health Equity and Policy Considerations for Pediatric and Adult Congenital Heart Disease Care among Minoritized Populations in the United States.

4. Mucocutaneous toxicities from MEK inhibitors: a scoping review of the literature

5. Relating Human Perception of Musicality to Prediction in a Predictive Coding Model

8. Risk factors and outcomes of melanoma in children and adolescents: A retrospective multicenter study

9. Variability in personal protective equipment in cross-sectional interventional abdominal radiology practices.

18. Hematopoietic stem cell transplant for adults with mixed phenotypic acute leukemia.

19. Early prediction of severe ICANS after standard-of-care CD19 CAR T-cell therapy using gradient-boosted classification trees.

20. Predictors of severe hematotoxicity after CAR T-cell therapy.

23. Risk Factors and Outcomes of Nonmelanoma Skin Cancer in Children and Young Adults

25. Investor learning and mutual fund flows

30. Early Prediction of Severe Icans after CD19 CAR T-Cell Therapy Based on Serum Ferritin Levels

31. Safety and Efficacy of Fully-Human-Binder-Bearing CD19 CAR T-Cell Therapy for Large B-Cell Lymphoma after Failure of Murine-Binder-Bearing CD19 CAR T-Cell Therapy

32. Identification and Prediction of Severe Hematologic Toxicity after CAR T-Cell Therapy Using Machine Learning-Based Time-Series Clustering

33. Identification of Predictors of CRS and Neurotoxicity Duration after Axicabtagene Ciloleucel Therapy

34. Planned Interim Analysis of a Phase 2 Investigator-Initiated Trial of Anakinra to Prevent CRS and Neurotoxicity after Treatment with Lisocabtagene Maraleucel

35. Real-World Comparison of Lisocabtagene Maraleucel (Liso-Cel) and Axicabtagene Ciloleucel (Axi-Cel): Efficacy & Toxicity

36. T-Cell Large Granular Lymphocyte Population Involving Chimeric Antigen Receptor-Modified T (CAR T) Cells in Patients with Cytopenia after CD19-Targeted CAR T-Cell Therapy: Case Series

38. Descriptive analysis of targeted carbapenemase genes and antibiotic susceptibility profiles among carbapenem-resistant Acinetobacter baumannii tested in the Antimicrobial Resistance Laboratory Network—United States, 2017–2020

39. Gram-Negative Bacteria Harboring Multiple Carbapenemase Genes, United States, 2012-2019

40. Exploring Human–AI Control Over Dynamic Transitions Between Individual and Collaborative Learning

44. Human herpesvirus 6 reactivation and disease are infrequent in chimeric antigen receptor T-cell therapy recipients

47. Coronary Anomalies

49. Vascular Endothelial Growth Factor C for Polycystic Kidney Diseases

50. Lisocabtagene maraleucel for relapsed or refractory large B-cell lymphoma: feasibility, safety and efficacy in a real-world setting

Catalog

Books, media, physical & digital resources